These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10202558)

  • 1. The complexities of CD28 and CTLA-4 signalling: PI3K and beyond.
    Ward SG
    Arch Immunol Ther Exp (Warsz); 1999; 47(2):69-75. PubMed ID: 10202558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28: a signalling perspective.
    Ward SG
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):361-77. PubMed ID: 8809021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
    Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
    Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
    Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is CTLA-4 a master switch for peripheral T cell tolerance?
    Bluestone JA
    J Immunol; 1997 Mar; 158(5):1989-93. PubMed ID: 9036940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
    Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CTLA-4 structure and expression on human T cells.
    Lindsten T; Lee KP; Harris ES; Petryniak B; Craighead N; Reynolds PJ; Lombard DB; Freeman GJ; Nadler LM; Gray GS
    J Immunol; 1993 Oct; 151(7):3489-99. PubMed ID: 8397258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
    Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
    J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the CD28 receptor during T cell responses to antigen.
    Linsley PS; Ledbetter JA
    Annu Rev Immunol; 1993; 11():191-212. PubMed ID: 8386518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD28 and CTLA-4 receptor family.
    June CH; Vandenberghe P; Thompson CB
    Chem Immunol; 1994; 59():62-90. PubMed ID: 7945930
    [No Abstract]   [Full Text] [Related]  

  • 20. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.
    Lucas PJ; Negishi I; Nakayama K; Fields LE; Loh DY
    J Immunol; 1995 Jun; 154(11):5757-68. PubMed ID: 7751626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.